To attend, please ensure that you are registered for the ASBMR annual meeting.
The goal of osteoporosis management is to prevent fractures. Osteoporosis is a “silent” chronic disease, often asymptomatic, until a bone breaks requiring a long-term treatment strategy, with the use of either antiresorptive or anabolic drugs limited to 18-24 months. Discontinuing antiosteoporosis drugs may result in rapidly declining bone mineral density (BMD). Studies have shown that bone anabolic treatments increase bone density, improve bone strength, and are more effective than bisphosphonates in the prevention of clinical and vertebral fractures, irrespective of baseline risk indicators. Join us as we review available treatment options contributing to fracture-risk reduction, allowing for interactive discussion between the presenters and audience members.
Schedule |
|
* Times are PST | |
12:45 PM | Luncheon |
12:55 PM | Welcome, Disclosures, Supporter Acknowledgement |
01:00 PM | Patients at Risk for Osteoporosis |
01:15 PM | Clinical Practice Gaps in Treatment |
01:20 PM | Opportunistic Use of Artificial Intelligence (AI) |
01:30 PM | Cohort Study Results on Hip Fracture Prevention |
01:45 PM | Closing Comments, Audience Q&A |
02:00 PM | Adjourn |
Felicia Cosman, MD
North American Co-Editor in Chief of Osteoporosis International
Bone Health and Osteoporosis Foundation
Professor Emerita of Medicine
Columbia University
New York, NY
Mashid Mohseni, MD
Director, Clinical Research Unit
Co-Director of Clinical Operations
Division of Bone and Mineral Disease
Assistant Professor of Medicine
Washington University School of Medicine
Saint Louis, MO
EXCEL Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
EXCEL Continuing Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The UEMS-EACCME®: The European Union of Medical Specialists and European Accreditation Council for CME have mutual recognition agreements with the American Medical Association. Under the terms of this agreement, the EACCME, the accrediting arm of the UEMS, will convert CME credit for live and enduring activities certified by the AMA.
Canadian CME: Through an agreement between the ACCME and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
Physician Assistants and Nurse Practitioners: The National Commission on Certification of Physician Assistants (NCCPA) and the American Academy of Nurse Practitioners (AANP) accept AMA PRA Category 1 Credit™ from organizations accredited by ACCME through its reciprocity agreements.
- Identify patients that may be at high risk for osteoporosis for prompt diagnosis and early treatment initiation
- Outline clinical practice gaps and common errors with postmenopausal osteoporosis care
- Evaluate available clinical trial data on risk reduction of fractures to support evidence-based treatment decisions